Shell Asset Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Sell |
1,332
-980
| -42% | -$10.3K | ﹤0.01% | 1243 |
|
|
2025
Q1 | $35K | Sell |
2,312
-97
| -4% | -$1.47K | ﹤0.01% | 1197 |
|
|
2024
Q4 | $40K | Hold |
2,409
| – | – | ﹤0.01% | 1199 |
|
|
2024
Q3 | $60K | Buy |
+2,409
| New | +$60K | ﹤0.01% | 1154 |
|
|
2024
Q1 | $64K | Sell |
2,545
-176
| -6% | -$4.43K | ﹤0.01% | 1115 |
|
|
2023
Q4 | $62K | Sell |
2,721
-779
| -22% | -$17.8K | ﹤0.01% | 1139 |
|
|
2023
Q3 | $65K | Sell |
3,500
-54
| -2% | -$1K | ﹤0.01% | 1158 |
|
|
2023
Q2 | $92K | Sell |
3,554
-21
| -0.6% | -$544 | ﹤0.01% | 1136 |
|
|
2023
Q1 | $103K | Sell |
3,575
-12
| -0.3% | -$346 | ﹤0.01% | 1095 |
|
|
2022
Q4 | $106K | Sell |
3,587
-354
| -9% | -$10.5K | ﹤0.01% | 1141 |
|
|
2022
Q3 | $94K | Sell |
3,941
-515
| -12% | -$12.3K | ﹤0.01% | 1251 |
|
|
2022
Q2 | $99K | Buy |
4,456
+57
| +1% | +$1.27K | ﹤0.01% | 1281 |
|
|
2022
Q1 | $110K | Sell |
4,399
-650
| -13% | -$16.3K | ﹤0.01% | 1279 |
|
|
2021
Q4 | $181K | Buy |
5,049
+29
| +0.6% | +$1.04K | ﹤0.01% | 1229 |
|
|
2021
Q3 | $214K | Sell |
5,020
-220
| -4% | -$9.38K | ﹤0.01% | 1183 |
|
|
2021
Q2 | $227K | Sell |
5,240
-3,681
| -41% | -$159K | ﹤0.01% | 1199 |
|
|
2021
Q1 | $364K | Buy |
8,921
+5,117
| +135% | +$209K | 0.01% | 975 |
|
|
2020
Q4 | $172K | Hold |
3,804
| – | – | ﹤0.01% | 1156 |
|
|
2020
Q3 | $135K | Hold |
3,804
| – | – | ﹤0.01% | 1120 |
|
|
2020
Q2 | $144K | Buy |
+3,804
| New | +$144K | ﹤0.01% | 1092 |
|